blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0553291

EP0553291 - TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.01.2007
Database last updated on 24.04.2024
Most recent event   Tooltip01.08.2008Lapse of the patent in a contracting state
New state(s): LU		published on 03.09.2008  [2008/36]
Applicant(s)For all designated states
AUTOIMMUNE, INC.
1199 Madia Street
Pasadena, CA 91103 / US
[2002/01]
Former [1995/45]For all designated states
AUTOIMMUNE, INC.
128 Spring Street
Lexington, MA 02174 / US
Former [1993/31]For all designated states
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis Street
Boston, Massachusetts 02115 / US
Inventor(s)01 / WEINER, Howard, L.
114 Somerset Road
Brookline, MA 02146 / US
02 / HAFLER, David, A.
110 Forest Avenue
West Newton, MA 02165 / US
[1993/31]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [1993/31]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
D-80538 München / DE
Application number, filing date92900084.215.10.1991
[1993/31]
WO1991US07542
Priority number, dateUS1990059693615.10.1990         Original published format: US 596936
[1993/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9206708
Date:30.04.1992
Language:EN
[1992/10]
Type: A1 Application with search report 
No.:EP0553291
Date:04.08.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 30.04.1992 takes the place of the publication of the European patent application.
[1993/31]
Type: B1 Patent specification 
No.:EP0553291
Date:08.03.2006
Language:EN
[2006/10]
Search report(s)International search report - published on:US30.04.1992
(Supplementary) European search report - dispatched on:EP13.10.1994
ClassificationIPC:A61K39/00, A61K39/36, A61K39/395
[1993/31]
CPC:
A61K38/39 (EP,US); A61K39/00 (KR); A61K39/0008 (EP,US);
A61K39/36 (KR); A61K39/395 (KR); A61P37/00 (EP);
A61P37/02 (EP); A61K2039/542 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/31]
TitleGerman:BEHANDLUNG VON AUTOIMMUNKRANKHEITEN DURCH ORALE VERABREICHUNG VON AUTOANTIGENEN[1993/31]
English:TREATMENT OF AUTOIMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTOANTIGENS[1993/31]
French:TRAITEMENT DE MALADIES AUTO-IMMUNES PAR ADMINISTRATION ORALE D'AUTO-ANTIGENES[1993/31]
Entry into regional phase15.04.1993National basic fee paid 
15.04.1993Search fee paid 
15.04.1993Designation fee(s) paid 
15.04.1993Examination fee paid 
Examination procedure07.05.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
15.04.1993Examination requested  [1993/31]
24.06.1998Despatch of a communication from the examining division (Time limit: M08)
04.03.1999Reply to a communication from the examining division
31.01.2000Despatch of a communication from the examining division (Time limit: M06)
10.08.2000Reply to a communication from the examining division
28.08.2001Despatch of a communication from the examining division (Time limit: M06)
12.04.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
21.06.2002Reply to a communication from the examining division
31.08.2005Communication of intention to grant the patent
04.01.2006Fee for grant paid
04.01.2006Fee for publishing/printing paid
Opposition(s)11.12.2006No opposition filed within time limit [2007/07]
Request for further processing for:21.06.2002Request for further processing filed
21.06.2002Full payment received (date of receipt of payment)
Request granted
11.07.2002Decision despatched
Fees paidRenewal fee
24.11.1993Renewal fee patent year 03
19.09.1994Renewal fee patent year 04
25.09.1995Renewal fee patent year 05
09.10.1996Renewal fee patent year 06
10.10.1997Renewal fee patent year 07
28.10.1998Renewal fee patent year 08
14.10.1999Renewal fee patent year 09
11.10.2000Renewal fee patent year 10
11.10.2001Renewal fee patent year 11
15.10.2002Renewal fee patent year 12
14.10.2003Renewal fee patent year 13
14.10.2004Renewal fee patent year 14
07.10.2005Renewal fee patent year 15
Penalty fee
Additional fee for renewal fee
01.11.199303   M06   Fee paid on   24.11.1993
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT08.03.2006
BE08.03.2006
NL08.03.2006
DK08.06.2006
SE08.06.2006
GR09.06.2006
LU15.10.2006
[2008/36]
Former [2008/21]AT08.03.2006
BE08.03.2006
NL08.03.2006
DK08.06.2006
SE08.06.2006
GR09.06.2006
Former [2007/16]AT08.03.2006
BE08.03.2006
NL08.03.2006
DK08.06.2006
SE08.06.2006
Former [2006/45]AT08.03.2006
NL08.03.2006
SE08.06.2006
Former [2006/43]AT08.03.2006
Documents cited:Search[XD]WO8810120  (BRIGHAM & WOMENS HOSPITAL [US]) [XD] 1-9 * page 6, line 1 - page 9, line 2 *;
 [XP]WO9108760  (BRIGHAM & WOMENS HOSPITAL [US], et al) [XP] 1-18* page 13, line 17 - page 21, line 4 *;
 [XP]WO9112816  (AUTOIMMUNE INC [US], et al) [XP] 1-18 * page 8, line 36 - page 16, line 23 *
 [XD]  - H. S. G. THOMPSON ET AL., "GASTRIC ADMINISTRATION OF TYPE II COLLAGEN DELAYS THE ONSET AND SEVERITY OF COLLAGEN-INDUCED ARTHRITIS IN RATS", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, (198606), vol. 64, no. 3, pages 581 - 586 [XD] 1,2,10-12 * the whole document *
 [XD]  - PAUL J. HIGGINS ET AL., "SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ORAL ADMINISTRATION OF MYELIN BASIC PROTEIN AND ITS FRAGMENTS.", JOURNAL OF IMMUNOLOGY, BALTIMORE US, (19880115), vol. 140, no. 2, pages 440 - 445 [XD] 1-9,13-18 * the whole document *
International search[Y]  - Cellular Immunology, Volume 75, issued April 1983, SRIRAM et al, "Administration of Myelin Basic Protein-coupled Spleen Cells Prevents Experimental Allergic Encephalitis", pages 378-382, see entire document.
 [Y]  - Proceedings National Academy of Sciences, Volume 83, issued October 1986, NAGLER-ANDERSON et al. "Suppression of Type II Colagen-Induced Arthritis by Intragastric Administration of Soluble Type II Collagen", pages 7443-7446, see entire document.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.